CoChat
Sign Up
Cited by 155

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Astrocyte–neuron interactions in neurological disorders

Ricci, G., Volpi, L., Pasquali, L., Petrozzi, L., Siciliano, G.·2009·Journal of Biological Physics
DOI 10.1007/s10867-009-9157-9
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10867-009-9157-9

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Insulin upregulates LPL activity in glial cells at the same time point where the lowest Angptl4 expression is detected, suggesting Angptl4 may play a role in LPL activity in glial cells.

    “Importantly, insulin upregulates LPL activity in glial cells at the same time point where the lowest Angptl4 expression was detected, suggesting that Angptl4 may play a role in LPL activity in glial cells and perhaps in the interplay known to exist between glial cells and neurons [34,35].”

    From Differential effects of angiopoietin-like 4 in brain and muscle on regulation of lipoprotein lipase activity (2015) · cites this paper as [35]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 133

  1. Bushong, E.A., Martone, M.E., Jones, Y.Z., Ellisman, M.H.: Protoplasmic astrocytes in CA1 stratum radiatum occupy separate anatomical domains. J. Neurosci. 22, 183–192 (2002) · DOI · Paper page
  2. Oberheim, N.A., Wang, X., Goldman, S., Nedergaard, M.: Astrocytic complexity distinguishes the human brain. Trends Neurosci. 29(10), 547–553 (2006). doi: 10.1016/j.tins.2006.08.004 · DOI · Paper page
  3. Ogata, K., Kosaka, T.: Structural and quantitative analysis of astrocytes in the mouse hippocampus. Neuroscience 113, 221–233 (2002). doi: 10.1016/S0306-4522(02)00041-6 · DOI · Paper page
  4. Kirchhoff, F., Dringen, R., Giaume, C.: Pathways of neuron–astrocyte interactions and their possible role in neuroprotection. Eur. Arch. Psychiatry Clin. Neurosci. 251(4), 159–169 (2001). doi: 10.1007/s004060170036 · DOI
  5. Alvarez-Maubecin, V., Garcia-Hernandez, F., Williams, J.T., Van Bockstaele, E.J.: Functional coupling between neurons and glia. J. Neurosci. 20(11), 4091–4098 (2000) · DOI
  6. Rouach, N., Glowinski, J., Giaume, C.: Activity-dependent neuronal control of gap-junctional communication in astrocytes. J. Cell Biol. 149, 1513–1526 (2000). doi: 10.1083/jcb.149.7.1513 · DOI
  7. Leybaert, L., Paemeleire, K., Strahonja, A., Sanderson, M.J.: Inositol-triphosphate-dependent intercellular calcium signalling in and between astrocytes and endothelial cells. Glia 24, 398–407 (1998). doi: 10.1002/(SICI)1098-1136(199812)24:4<398::AID-GLIA5>3.0.CO;2-R · DOI
  8. Medina, J.M., Giaume, C., Tabernero, A.: Metabolic coupling and the role played by astrocytes in energy distribution and homeostasis. Adv. Exp. Med. Biol. 468, 361–371 (1999) · DOI
  9. Bass, N.H., Hess, H.H., Pope, A., Thalheimer, C.: Quantitative cytoarchitectonic distribution of neurons, glia, and DNA in rat cerebral cortex. J. Comp. Neurol. 143, 481–490 (1971). doi: 10.1002/cne.901430405 · DOI
  10. Nett, W.J., Oloff, S.H., McCarthy, K.D.: Hippocampal astrocytes in situ exhibit calcium oscillations that occur independent of neuronal activity. J. Neurophysiol. 87, 528–537 (2002) · DOI
  11. Parri, H.R., Gould, T.M., Crunelli, V.: Spontaneous astrocytic Ca2+ oscillations in situ drive NMDAR-mediated neuronal excitation. Nat. Neurosci. 4, 803–812 (2001). doi: 10.1038/90507 · DOI
  12. Volterra, A., Meldolesi, J.: Astrocytes, from brain glue to communication elements: the revolution continues. Nat. Rev. Neurosci. 6(8), 626–640 (2005). doi: 10.1038/nrn1722 · DOI
  13. Hansson, E., Rönnbäck, L.: Glial neuronal signaling in the central nervous system. FASEB J. 17(3), 341–348 (2003). doi: 10.1096/fj.02-0429rev · DOI
  14. Zonta, M., Carmignoto, G.: Calcium oscillations encoding neuron-to-astrocyte communication. J. Physiol. (Paris) 96(3–4), 193–198 (2002). doi: 10.1016/S0928-4257(02)00006-2 · DOI
  15. Maragakis, N.J., Rothstein, J.D.: Mechanisms of disease: astrocytes in neurodegenerative disease. Nat. Clin. Pract. Neurol. 2(12), 679–689 (2006). doi: 10.1038/ncpneuro0355 · DOI
  16. Abbott, N.J.: Astrocyte–endothelial interactions and blood–brain barrier permeability. J. Anat. 200, 629–638 (2002). doi: 10.1046/j.1469-7580.2002.00064.x · DOI · Paper page
  17. Del Zoppo, G.J., Hallenbeck, J.M.: Advances in the vascular pathophysiology of ischemic stroke. Thromb. Res. 98, 73–81 (2000). doi: 10.1016/S0049-3848(00)00218-8 · DOI
  18. Takano, T., Tian, G.F., Peng, W., Lou, N., Libionka, W., Han, X., Nedergaard, M.: Astrocyte-mediated control of cerebral blood flow. Nat. Neurosci. 9(2), 260–267 (2006). doi: 10.1038/nn1623 · DOI
  19. Rubino, E., Rainero, I., Vaula, G., Crasto, F., Gravante, E., Negro, E., Brega, F., Gallone, S., Pinessi, L.: Investigating the genetic role of aquaporin4 gene in migraine. J. Headache Pain 10(2), 111–114 (2009). doi: 10.1007/s10194-009-0100-z · DOI
  20. Nakahama, K., Nagano, M., Fujioka, A., Shinoda, K., Sasaki, H.: Effect of TPA on aquaporin 4 mRNA expression in cultured rat astrocytes. Glia 25, 240–246 (1999). doi: 10.1002/(SICI)1098-1136(19990201)25:3<240::AID-GLIA4>3.0.CO;2-C · DOI
  21. Clarke, D.D., Sokoloff, L.: Circulation and energy metabolism of the brain. In: Sigel, G.J., Agranoff, B.W., Albers, R.W., Fisher, S.K., Uhler, M.D. (eds.) Basic Neurochemistry: Molecular, Cellular and Medical Aspects, pp. 637–699. Lippincott-Raven, Philadelphia (1999)
  22. Somjen, G.G.: Nervenkitt: notes on the history of the concept of neuroglia. Glia 1, 2–9 (1988). doi: 10.1002/glia.440010103 · DOI
  23. Wiesinger, H., Hamprecht, B., Dringen, R.: Metabolic pathways for glucose in astrocytes. Glia 21, 22–34 (1997). doi: 10.1002/(SICI)1098-1136(199709)21:1<22::AID-GLIA3>3.0.CO;2-3 · DOI · Paper page
  24. Chih, C.P., Roberts, E.L., Jr.: Energy substrates for neurons during neural activity: a critical review of the astrocyte–neuron lactate shuttle hypothesis. J. Cereb. Blood Flow Metab. 23(11), 1263–1281 (2003). doi: 10.1097/01.WCB.0000081369.51727.6F · DOI
  25. Auestad, N., Korsak, R.A., Morrow, J.W., Edmond, J.: Fatty acid oxidation and ketogenesis by astrocytes in primary culture. Neurochemistry 56, 1376–1386 (1991). doi: 10.1111/j.1471-4159.1991.tb11435.x · DOI
  26. Bixel, M.G., Hamprecht, B.: Generation of ketone bodies from leucine by cultured astroglial cells. J. Neurochem. 65, 2450–2461 (1995) · DOI
  27. Canevari, L., Clark, J.B.: Alzheimer’s disease and cholesterol: the fat connection. Neurochem. Res. 32(4–5), 739–750 (2007). doi: 10.1007/s11064-006-9200-1 · DOI
  28. Kofuji, P., Newman, E.A.: Potassium buffering in the central nervous system. Neuroscience 129(4), 1045–1056 (2004). doi: 10.1016/j.neuroscience.2004.06.008 · DOI
  29. Dringen, R., Gutterer, J.M., Hirrlinger, J.: Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. Eur. J. Biochem. 267, 4912–4916 (2000). doi: 10.1046/j.1432-1327.2000.01597.x · DOI
  30. Schulz, J.B., Lindenau, J., Seyfried, J., Dichgans, J.: Glutathione, oxidative stress and neurodegeneration. Eur. J. Biochem. 267, 4904–4911 (2000). doi: 10.1046/j.1432-1327.2000.01595.x · DOI
  31. Kranich, O., Hamprecht, B., Dringen, R.: Different preferences in the utilization of amino acids for glutathione synthesis in cultured neurons and astroglial cells derived from rat brain. Neurosci. Lett. 219, 211–214 (1996). doi: 10.1016/S0304-3940(96)13217-1 · DOI · Paper page
  32. Dringen, R., Kranich, O., Hamprecht, B.: The gamma-glutamyl transpeptidase inhibitor acivicin preserves glutathione released by astroglial cells in culture. Neurochem. Res. 22, 727–733 (1997). doi: 10.1023/A:1027310328310 · DOI
  33. Dringen, R., Pfeiffer, B., Hamprecht, B.: Synthesis of the antioxidant glutathione in neurons: supply by astrocytes of CysGly as precursor for neuronal glutathione. J. Neurosci. 19, 562–569 (1999) · DOI · Paper page
  34. Mauch, D.H., Nagler, K., Schumacher, S., Goritz, C., Muller, E.C., Otto, A., Pfrieger, F.W.: CNS synaptogenesis promoted by glia-derived cholesterol. Science 294, 1354–1357 (2001). doi: 10.1126/science.294.5545.1354 · DOI · Paper page
  35. Ullian, E.M., Sapperstein, S.K., Christopherson, K.S., Barres, B.A.: Control of synapse number by glia. Science 291, 657–661 (2001). doi: 10.1126/science.291.5504.657 · DOI · Paper page
  36. Pfrieger, F.W., Barres, B.A.: Synaptic efficacy enhanced by glial cells in vitro. Science 277, 1684–1687 (1997). doi: 10.1126/science.277.5332.1684 · DOI
  37. Klein, R.: Bidirectional modulation of synaptic functions by Eph/ephrin signalling. Nat. Neurosci. 12, 15–20 (2009). doi: 10.1038/nn.2231 · DOI
  38. Piet, R., Vargova, L., Sykova, E., Poulain, D.A., Oliet, S.H.: Physiological contribution of the astrocytic environment of neurons to intersynaptic crosstalk. Proc. Natl. Acad. Sci. U. S. A. 101, 2151–2155 (2004). doi: 10.1073/pnas.0308408100 · DOI · Paper page
  39. Giaume, C., McCarthy, K.D.: Control of gap-junctional communication in astrocytic networks. Trends Neurosci. 19(8), 319–325 (1996). doi: 10.1016/0166-2236(96)10046-1 · DOI
  40. Todd, K.J., Serrano, A., Lacaille, J.C., Robitaille, R.: Glial cells in synaptic plasticity. J. Physiol. (Paris) 99, 75–83 (2006). doi: 10.1016/j.jphysparis.2005.12.002 · DOI
  41. Allen, N.J., Barres, B.A.: Signaling between glia and neurons: focus on synaptic plasticity. Curr. Opin. Neurobiol. 15(5), 542–548 (2005). doi: 10.1016/j.conb.2005.08.006 · DOI
  42. Anderson, C.M., Swanson, R.A.: Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia 32, 1–14 (2000). doi: 10.1002/1098-1136(200010)32:1<1::AID-GLIA10>3.0.CO;2-W · DOI
  43. Araque, A., Li, N., Doyle, R.T., Haydon, P.G.: SNARE protein-dependent glutamate release from astrocytes. J. Neurosci. 20, 666–673 (2000) · DOI
  44. Clements, J.D., Lester, R.A., Tong, G., Jahr, C.E., Westbrook, G.L.: The time course of glutamate in the synaptic cleft. Science 258, 1498–1501 (1992). doi: 10.1126/science.1359647 · DOI
  45. Bergles, D.E., Jahr, C.E.: Glial contribution to glutamate uptake at Schaffer collateral-commissural synapses in the hippocampus. J. Neurosci. 18, 7709–7716 (1998) · DOI
  46. Ye, Z.C., Wyeth, M.S., Baltan-Tekkok, S., Ransom, B.R.: Functional hemichannels in astrocytes: a novel mechanism of glutamate release. J. Neurosci. 23(9), 3588–3596 (2003) · DOI
  47. Kvamme, E., Roberg, B., Torgner, I.A.: Phosphate-activated glutaminase and mitochondrial glutamine transport in the brain. Neurochem. Res. 25, 1407–1419 (2000). doi: 10.1023/A:1007668801570 · DOI
  48. Fam, S.R., Gallagher, C.J., Salter, M.W.: P2Y(1) purinoceptor mediated Ca(2+) signaling and Ca(2+) wave propagation in dorsal spinal cord astrocytes. J. Neurosci. 20, 2800–2808 (2000) · DOI
  49. Neary, J.T., McCarthy, M., Cornell-Bell, A., Kang, Y.: Trophic signaling pathways activated by purinergic receptors in rat and human astroglia. Prog. Brain Res. 120, 323–332 (1999). doi: 10.1016/S0079-6123(08)63566-9 · DOI
  50. Priller, J., Reddington, M., Haas, C.A., Kreutzberg, G.W.: Stimulation of P2Y-purinoceptors on astrocytes results in immediate early gene expression and potentiation of neuropeptide action. Neuroscience 85(2), 521–525 (1998). doi: 10.1016/S0306-4522(97)00653-2 · DOI
  51. Conde, J.R., Streit, W.J.: Microglia in the aging brain. J. Neuropathol. Exp. Neurol. 65, 199–203 (2006) · DOI · Paper page
  52. Heneka, M.T., O’Banion, M.K.: Inflammatory processes in Alzheimer’s disease. J. Neuroimmunol. 184, 69–91 (2007). doi: 10.1016/j.jneuroim.2006.11.017 · DOI · Paper page
  53. Fetler, L., Amigorena, S.: Neuroscience. Brain under surveillance: the microglia patrol. Science 309, 392–393 (2005). doi: 10.1126/science.1114852 · DOI
  54. Banati, R.B., Gehrmann, J., Schubert, P., Kreutzberg, G.W.: Cytotoxicity of microglia. Glia 7(1), 111–118 (1993). doi: 10.1002/glia.440070117 · DOI
  55. Liu, B., Hong, J.S.: Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J. Pharmacol. Exp. Ther. 304, 1–7 (2003). doi: 10.1124/jpet.102.035048 · DOI · Paper page
  56. Bruce-Keller, A.J.: Microglial–neuronal interactions in synaptic damage and recovery. J. Neurosci. Res. 58, 191–201 (1999). doi: 10.1002/(SICI)1097-4547(19991001)58:1<191::AID-JNR17>3.0.CO;2-E · DOI
  57. Frohman, E.M., van den Noort, S., Gupta, S.: Astrocytes and intracerebral immune responses. J. Clin. Immunol. 9(1), 1–9 (1989). doi: 10.1007/BF00917121 · DOI
  58. Schipke, C.G., Boucsein, C., Ohlemeyer, C., Kirchhoff, F., Kettenmann, H.: Astrocyte Ca2+ waves trigger responses in microglial cells in brain slices. FASEB J. 16(2), 255–257 (2002) · DOI
  59. Ciccarelli, R., Di Iorio, P., D’Alimonte, I., Giuliani, P., Florio, T., Caciagli, F., Middlemiss, P.J., Rathbone, M.P.: Cultured astrocyte proliferation induced by extracellular guanosine involves endogenous adenosine and is raised by the co-presence of microglia. Glia 29, 202–211 (2000). doi: 10.1002/(SICI)1098-1136(20000201)29:3<202::AID-GLIA2>3.0.CO;2-C · DOI
  60. Illes, P., Nörenberg, W., Gebicke-Haerter, P.J.: Molecular mechanisms of microglial activation. B. Voltage- and purinoceptor-operated channels in microglia. Neurochem. Int. 29, 13–24 (1996). doi: 10.1016/0197-0186(95)00133-6 · DOI
  61. John, G.R., Scemes, E., Suadicani, S.O., Liu, J.S., Charles, P.C., Lee, S.C., Spray, D.C., Brosnan, C.F.: IL-1beta differentially regulates calcium wave propagation between primary human fetal astrocytes via pathways involving P2 receptors and gap junction channels. Proc. Natl. Acad. Sci. U. S. A. 96, 11613–11618 (1999) doi: 10.1073/pnas.96.20.11613 · DOI
  62. Verderio, C., Matteoli, M.: ATP mediates calcium signaling between astrocytes and microglial cells: modulation by IFN-γ. J. Immunol. 166, 6383–6391 (2001) · DOI
  63. Heales, S.J., Lam, A.A., Duncan, A.J., Land, J.M.: Neurodegeneration or neuroprotection: the pivotal role of astrocytes. Neurochem. Res. 29(3), 513–519 (2004). doi: 10.1023/B:NERE.0000014822.69384.0f · DOI
  64. Mehta, S.L., Manhas, N., Raghubir, R.: Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Res. Rev. 54(1), 34–66 (2007). doi: 10.1016/j.brainresrev.2006.11.003 · DOI
  65. Giffard, R.G., Swanson, R.A.: Ischemia-induced programmed cell death in astrocytes. Glia 50(4), 299–306 (2005). doi: 10.1002/glia.20167 · DOI
  66. Mori, T., Tateishi, N., Kagamiishi, Y., Shimoda, T., Satoh, S., Ono, S., Katsube, N., Asano, T.: Attenuation of a delayed increase in the extracellular glutamate level in the peri-infarct area following focal cerebral ischemia by a novel agent ONO-2506. Neurochem. Int. 45(2–3), 381–387 (2004). doi: 10.1016/j.neuint.2003.06.001 · DOI
  67. Bambrick, L., Kristian, T., Fiskum, G.: Astrocyte mitochondrial mechanisms of ischemic brain injury and neuroprotection. Neurochem. Res. 29(3), 601–608 (2004). doi: 10.1023/B:NERE.0000014830.06376.e6 · DOI
  68. Nita, D.A., Nita, V., Spulber, S., Moldovan, M., Popa, D.P., Zagrean, A.M., Zagrean, L.: Oxidative damage following cerebral ischemia depends on reperfusion—a biochemical study in rat. J. Cell. Mol. Med. 5(2), 163–170 (2001). doi: 10.1111/j.1582-4934.2001.tb00149.x · DOI
  69. Anderson, M.F., Sims, N.R.: The effects of focal ischemia and reperfusion on the glutathione content of mitochondria from rat brain subregions. J. Neurochem. 81(3), 541–549 (2002). doi: 10.1046/j.1471-4159.2002.00836.x · DOI
  70. Papadopoulos, M.C., Koumenis, I.L., Dugan, L.L., Giffard, R.G.: Vulnerability to glucose deprivation injury correlates with glutathione levels in astrocytes. Brain Res. 748(1–2), 151–156 (1997). doi: 10.1016/S0006-8993(96)01293-0 · DOI
  71. Chen, Y., Vartiainen, N.E., Ying, W., Chan, P.H., Koistinaho, J., Swanson, R.A.: Astrocytes protect neurons from nitric oxide toxicity by a glutathione-dependent mechanism. J. Neurochem. 77(6), 1601–1610 (2001). doi: 10.1046/j.1471-4159.2001.00374.x · DOI
  72. Fukuda, S., Fini, C.A., Mabuchi, T., Koziol, J.A., Eggleston, L.L., Jr., del Zoppo, G.J.: Focal cerebral ischemia induces active proteases that degrade microvascular matrix. Stroke 35(4), 998–1004 (2004). doi: 10.1161/01.STR.0000119383.76447.05 · DOI
  73. Del Zoppo, G.J.: Stroke and neurovascular protection. N. Engl. J. Med. 354(6), 553–555 (2006). doi: 10.1056/NEJMp058312 · DOI
  74. Huang, J., Choudhri, T.F., Winfree, C.J., McTaggart, R.A., Kiss, S., Mocco, J., Kim, L.J., Protopsaltis, T.S., Zhang, Y., Pinsky, D.J., Connolly, E.S., Jr.: Postischemic cerebrovascular E-selectin expression mediates tissue injury in murine stroke. Stroke 31(12), 3047–3053 (2000) · DOI
  75. Yenari, M.A., Xu, L., Tang, X.N., Qiao, Y., Giffard, R.G.: Microglia potentiate damage to blood-brain barrier constituents: improvement by minocycline in vivo and in vitro. Stroke 37(4), 1087–1093 (2006). doi: 10.1161/01.STR.0000206281.77178.ac · DOI · Paper page
  76. Anderson, M.F., Blomstrand, F., Blomstrand, C., Eriksson, P.S., Nilsson, M.: Astrocytes and stroke: networking for survival? Neurochem. Res. 28(2), 293–305 (2003). doi: 10.1023/A:1022385402197 · DOI
  77. Thoren, A.E., Helps, S.C., Nilsson, M., Sims, N.R.: Astrocytic function assessed from 1-14C-acetate metabolism after temporary focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 25(4), 440–450 (2005). doi: 10.1038/sj.jcbfm.9600035 · DOI
  78. Kimelberg, H.K.: Tamoxifen as a powerful neuroprotectant in experimental stroke and implications for human stroke therapy. Recent Pat. CNS Drug Discov. 3(2), 104–108 (2008) · DOI
  79. Wakade, C., Khan, M.M., De Sevilla, L.M., Zhang, Q.G., Mahesh, V.B., Brann, D.W.: Tamoxifen neuroprotection in cerebral ischemia involves attenuation of kinase activation and superoxide production and potentiation of mitochondrial superoxide dismutase. Endocrinology 149(1), 367–379 (2008). doi: 10.1210/en.2007-0899 · DOI
  80. Kimelberg, H.K.: Astrocytic swelling in cerebral ischemia as a possible cause of injury and target for therapy. Glia 50(4), 389–397 (2005). doi: 10.1002/glia.20174 · DOI · Paper page
  81. Nilsson, M., Pekny, M.: Enriched environment and astrocytes in central nervous system regeneration. J. Rehabil. Med. 39(5), 345–352 (2007). doi: 10.2340/16501977-0084 · DOI
  82. Cutrer, F.M., Huerter, K.: Migraine aura. Neurologist 13(3), 118–125 (2007). doi: 10.1097/01.nrl.0000252943.82792.38 · DOI
  83. Sanchez-Del-Rio, M., Reuter, U., Moskowitz, M.A.: New insights into migraine pathophysiology. Curr. Opin. Neurol. 19, 294–298 (2006). doi: 10.1097/01.wco.0000227041.23694.5c · DOI
  84. Strong, A.J., Dardis, R.: Depolarisation phenomena in traumatic and ischaemic brain injury. In: Pickard, J.D. (eds.) Advances and Technical Standards in Neurosurgery, pp. 3–49. Springer, Wien (2005) · DOI
  85. Martins-Ferreira, H., Nedergaard, M., Nicholson, C.: Perspectives on spreading depression. Brain Res. Brain Res. Rev. 32, 215–234 (2000). doi: 10.1016/S0165-0173(99)00083-1 · DOI
  86. Silberstein, S.D.: Migraine pathophysiology and its clinical implications. Cephalalgia 24(Suppl 2), 2–7 (2004). doi: 10.1111/j.1468-2982.2004.00892.x · DOI
  87. Smith, J.M., Bradley, D.P., James, M.F., Huang, C.L.: Physiological studies of cortical spreading depression. Biol. Rev. Camb. Philos. Soc. 81(4), 457–481 (2006). doi: 10.1017/S1464793106007081 · DOI
  88. Ducros, A.: Familial and sporadic hemiplegic migraine. Rev. Neurol. (Paris) 164(3), 216–224 (2008). doi: 10.1016/j.neurol.2007.10.003 · DOI
  89. Capendeguy, O., Horisberger, J.D.: Functional effects of Na+, K+-ATPase gene mutations linked to familial hemiplegic migraine. Neuromol. Med. 6, 105–116 (2004). doi: 10.1385/NMM:6:2-3:105 · DOI
  90. Blume, W., Lüders, H., Mizrahi, E., Tassinari, C., van Emde Boas, W., Engel, J.: Glossary of descriptive terminology for ictal semiology: report of the ILAE task force on classification and terminology. Epilepsia 42(9), 1212–1218 (2001). doi: 10.1046/j.1528-1157.2001.22001.x · DOI
  91. Choi, J., Koh, S.: Role of brain inflammation in epileptogenesis. Yonsei Med. J. 49(1), 1–18 (2008). doi: 10.3349/ymj.2008.49.1.1 · DOI
  92. Korn, A., Golan, H., Melamed, I., Pascual-Marqui, R., Friedman, A.: Focal cortical dysfunction and blood–brain barrier disruption in patients with postconcussion syndrome. J. Clin. Neurophysiol. 22, 1–9 (2005). doi: 10.1097/01.WNP.0000150973.24324.A7 · DOI
  93. Schroder, W., Seifert, G., Huttmann, K., Hinterkeuser, S., Steinhauser, C.: AMPA receptor-mediated modulation of inward rectifier K+ channels in astrocytes of mouse hippocampus. Mol. Cell. Neurosci. 19, 447–458 (2002). doi: 10.1006/mcne.2001.1080 · DOI
  94. Jansen, L.A., Uhlmann, E.J., Crino, P.B., Gutmann, D.H., Wong, M.: Epileptogenesis and reduced inward rectifier potassium current in tuberous sclerosis complex-1-deficient astrocytes. Epilepsia 46, 1871–1880 (2005). doi: 10.1111/j.1528-1167.2005.00289.x · DOI
  95. Proper, E.A., Hoogland, G., Kappen, S.M., Jansen, G.H., Rensen, M.G., Schrama, L.H., van Veelen, C.W., van Rijen, P.C., van Nieuwenhuizen, O., Gispen, W.H., de Graan, P.N.: Distribution of glutamate transporters in the hippocampus of patients with pharmaco-resistant temporal lobe epilepsy. Brain 125, 32–43 (2002). doi: 10.1093/brain/awf001 · DOI
  96. Tian, G.F., Azmi, H., Takano, T., Xu, Q., Peng, W., Lin, J., Oberheim, N., Lou, N., Wang, X., Zielke, H.R., Kang, J., Nedergaard, M.: An astrocytic basis of epilepsy. Nat. Med. 11(9), 973–981 (2005) · DOI · Paper page
  97. Willenborg, D.O., Fordham, S.A., Cowden, W.B., Ramshaw, I.A.: Cytokines and murine autoimmune encephalomyelitis: inhibition or enhancement of disease with antibodies to select cytokines, or by delivery of exogenous cytokines using a recombinant vaccinia virus system. Scand. J. Immunol. 41(1), 31–41 (1995). doi: 10.1111/j.1365-3083.1995.tb03530.x · DOI
  98. Nair, A., Frederick, T.J., Miller, S.D.: Astrocytes in multiple sclerosis: a product of their environment. Cell. Mol. Life Sci. 65, 2702–2720 (2008). doi: 10.1007/s00018-008-8059-5 · DOI
  99. Farina, C., Aloisi, F., Meinl, E.: Astrocytes are active players in cerebral innate immunity. Trends Immunol. 28, 138–145 (2007). doi: 10.1016/j.it.2007.01.005 · DOI · Paper page
  100. De Keyser, J., Wilczak, N., Leta, R., Streetland, C.: Astrocytes in multiple sclerosis lack beta-2 adrenergic receptors. Neurology 53, 1628–1633 (1999) · DOI
  101. Dong, Y., Benveniste, E.N.: Immune function of astrocytes. Glia 36, 180–190 (2001). doi: 10.1002/glia.1107 · DOI
  102. Gimenez, M.A., Sim, J.E., Russell, J.H.: TNFR1-dependent VCAM-1 expression by astrocytes exposes the CNS to destructive inflammation. J. Neuroimmunol. 151, 116–125 (2004). doi: 10.1016/j.jneuroim.2004.02.012 · DOI
  103. De Keyser, J., Zeinstra, E., Wilczak, N.: Astrocytic beta2-adrenergic receptors and multiple sclerosis. Neurobiol. Dis. 15, 331–339 (2004). doi: 10.1016/j.nbd.2003.10.012 · DOI
  104. Holley, J.E., Gveric, D., Newcombe, J., Cuzner, M.L., Gutowski, N.J.: Astrocyte characterization in the multiple sclerosis glial scar. Neuropathol. Appl. Neurobiol. 29, 434–444 (2003). doi: 10.1046/j.1365-2990.2003.00491.x · DOI
  105. Thomas, B., Flint Beal, M.: Parkinson’s disease. Hum. Mol. Genet. 16, R183–R194 (2007). doi: 10.1093/hmg/ddm159 · DOI · Paper page
  106. Sheng, J.G., Shirabe, S., Nishiyama, N., Schwartz, J.P.: Alterations in striatal glial fibrillary acidic protein expression in response to 6-hydroxydopamine-induced denervation. Exp. Brain Res. 95, 450–456 (1993). doi: 10.1007/BF00227138 · DOI
  107. Kohutnicka, M., Lewandowska, E., Kurkowska-Jastrzebska, I., Czlonkowski, A., Czlonkowska, A.: Microglial and astrocytic involvement in a murine model of Parkinson’s disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Immunopharmacology 39, 167–180 (1998). doi: 10.1016/S0162-3109(98)00022-8 · DOI
  108. Hunot, S., Bernard, V., Faucheux, B., Boissiere, F., Leguern, E., Brana, C., Gautris, P.P., Guerin, J., Bloch, B., Agid, Y., Hirsch, E.C.: Glial cell line-derived neurotrophic factor (GDNF) gene expression in the human brain: a post mortem in situ hybridization study with special reference to Parkinson’s disease. J. Neural Transm. 103, 1043–1052 (1996). doi: 10.1007/BF01291789 · DOI
  109. Kordower, J.H., Palfi, S., Chen, E.Y., Ma, S.Y., Sendera, T., Cochran, E.J., Cochran, E.J., Mufson, E.J., Penn, R., Goetz, C.G., Comella, C.D.: Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson’s disease. Ann. Neurol. 46, 419–424 (1999). doi: 10.1002/1531-8249(199909)46:3<419::AID-ANA21>3.0.CO;2-Q · DOI
  110. Emerit, J., Edeas, M., Bricaire, F.: Neurodegenerative diseases and oxidative stress. Biomed. Pharmacother. 58(1), 39–46 (2004). doi: 10.1016/j.biopha.2003.11.004 · DOI
  111. Dexter, D.T., Carter, C.J., Wells, F.R., Javoy-Agid, F., Agid, Y., Lees, A., Jenner, P., Marsden, C.D.: Basal lipid peroxidation in substantia nigra is increased in Parkinson’s disease. J. Neurochem. 52, 381–389 (1989). doi: 10.1111/j.1471-4159.1989.tb09133.x · DOI
  112. Kastner, A., Hirsch, E.C., Lejeune, O., Javoy-Agid, F., Rascol, O., Agid, Y.: Is the vulnerability of neurons in the substantia nigra of patients with Parkinson’s disease related to their neuromelanin content? J. Neurochem. 59, 1080–1089 (1992). doi: 10.1111/j.1471-4159.1992.tb08350.x · DOI
  113. Jellinger, K., Kienzl, E., Rumpelmair, G., Riederer, P., Stachelberger, H., Ben-Shachar, D., Youdim, M.B.: Iron melanin complex in substantia nigra of parkinsonian brains: an X-ray microanalysis. J. Neurochem. 59, 1168–1171 (1992). doi: 10.1111/j.1471-4159.1992.tb08362.x · DOI · Paper page
  114. Sian, J., Dexter, D.T., Lees, A.J., Daniel, S., Agid, Y., Javoy-Agid, F., Jenner, P., Marsden, C.D.: Alterations in glutathione levels in Parkinson’s disease and other neurodegenerative disorders affecting basal ganglia. Ann. Neurol. 36, 348–355 (1994). doi: 10.1002/ana.410360305 · DOI · Paper page
  115. Desagher, S., Glowinski, J., Premont, J.: Pyruvate protects neurons against hydrogen peroxide-induced toxicity. J. Neurosci. 1, 9060–9067 (1997) · DOI
  116. Kastner, A., Anglade, P., Bounaix, C., Damier, P., Javoy-Agid, F., Bromet, N., Agid, Y., Hirsch, E.C.: Immunohistochemical study of catechol-O methyltransferase in the human mesostriatal system. Neuroscience 62, 449–457 (1994). doi: 10.1016/0306-4522(94)90379-4 · DOI
  117. Hunot, S., Dugas, N., Faucheux, B., Hartmann, A., Tardieu, M., Debre, P., Agid, Y., Dugas, B., Hirsch, E.C.: FcεRII/CD23 is expressed in Parkinson’s disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells. J. Neurosci. 19, 3440–3447 (1999) · DOI
  118. Mogi, M., Harada, M., Narabayashi, H., Inagaki, H., Minami, M., Nagatsu, T.: Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson’s disease. Neurosci. Lett. 211, 13–16 (1996). doi: 10.1016/0304-3940(96)12706-3 · DOI · Paper page
  119. Mogi, M., Harada, M., Riederer, P., Narabayashi, H., Fujita, K., Nagatsu, T.: Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci. Lett. 165, 208–210 (1994). doi: 10.1016/0304-3940(94)90746-3 · DOI · Paper page
  120. Mogi, M., Harada, M., Kondo, T., Riederer, P., Nagatsu, T.: Brain beta 2-microglobulin levels are elevated in the striatum in Parkinson’s disease. J. Neural Transm. Parkinson’s Dis. Dement. Sect. 9, 87–92 (1995). doi: 10.1007/BF02252965 · DOI
  121. Dugas, B., Mossalayi, M.D., Damais, C., Kolb, J.P.: Nitric oxide production by human monocytes: evidence for a role of CD23. Immunol. Today 16, 574–580 (1995). doi: 10.1016/0167-5699(95)80080-8 · DOI
  122. Arock, M., Le Goff, L., Becherel, P.A., Dugas, B., Debre, P., Mossalayi, M.D.: Involvement of FcεRII/CD23 and L-arginine dependent pathway in IgE-mediated activation of human eosinophils. Biochem. Biophys. Res. Commun. 203, 265–271 (1994). doi: 10.1006/bbrc.1994.2177 · DOI
  123. Juckett, M., Zheng, Y., Yuan, H., Pastor, T., Antholine, W., Weber, M., Vercellotti, G.: Heme and the endothelium. Effects of nitric oxide on catalytic iron and heme degradation by heme oxygenase. J. Biol. Chem. 273(36), 23388–23397 (1998). doi: 10.1074/jbc.273.36.23388 · DOI
  124. O’Banion, M.K.: Cyclooxygenase-2: molecular biology, pharmacology, and neurobiology. Crit. Rev. Neurobiol. 13, 45–82 (1999) · DOI
  125. Teismann, P., Tieu, K., Choi, D.K., Wu, D.C., Naini, A., Hunot, S., Vila, M., Jackson-Lewis, V., Przedborski, S.: Cyclooxygenase-2 is instrumental in Parkinson’s disease neurodegeneration. Proc. Natl. Acad. Sci. U. S. A. 100, 5473–5478 (2003). doi: 10.1073/pnas.0837397100 · DOI
  126. Mogi, M., Togari, A., Kondo, T., Mizuno, Y., Komure, O., Kuno, S., Ichinose, H., Nagatsu, T.: Caspase activities and tumor necrosis factor receptor R1 (p55) level are elevated in the substantia nigra from parkinsonian brain. J. Neural Transm. 107, 335–341 (2000). doi: 10.1007/s007020050028 · DOI
  127. Rocchi, A., Pellegrini, S., Siciliano, G., Murri, L.: Causative and susceptibility genes for Alzheimer’s disease: a review. Brain Res. Bull. 61(1), 1–24 (2003). doi: 10.1016/S0361-9230(03)00067-4 · DOI
  128. Rossner, S., Lange-Dohna, C., Zeitschel, U., Perez-Polo, J.R.: Alzheimer’s disease beta-secretase BACE1 is not a neuron-specific enzyme. J. Neurochem. 92(2), 226–234 (2005). doi: 10.1111/j.1471-4159.2004.02857.x · DOI
  129. Meda, L., Baron, P., Scarlato, G.: Glial activation in Alzheimer’s disease: the role of Aβ and its associated proteins. Neurobiol. Aging 22(6), 885–893 (2001). doi: 10.1016/S0197-4580(01)00307-4 · DOI · Paper page
  130. Schubert, P., Ogata, T., Marchini, C., Ferroni, S.: Glia-related pathomechanisms in Alzheimer’s disease: a therapeutic target? Mech. Ageing Dev. 123(1), 47–57 (2001). doi: 10.1016/S0047-6374(01)00343-8 · DOI
  131. Heneka, M.T., Sastre, M., Dumitrescu-Ozimek, L., Dewachter, I., Walter, J., Klockgether, T., Van Leuven, F.: Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice. J. Neuroinflammation 2, 22 (2005). doi: 10.1186/1742-2094-2-22 · DOI · Paper page
  132. Colombo, J.A., Quinn, B., Puissant, V.: Disruption of astroglial interlaminar processes in Alzheimer’s disease. Brain Res. Bull. 58(2), 235–242 (2002). doi: 10.1016/S0361-9230(02)00785-2 · DOI · Paper page
  133. Mattson, M.P., Chan, S.L.: Calcium orchestrates apoptosis. Nat. Cell Biol. 5(12), 1051–1061 (2003). doi: 10.1038/ncb1203-1041 · DOI

Cited by

Sorted by citations

Metadata

Authors
Ricci, G., Volpi, L., Pasquali, L., Petrozzi, L., & Siciliano, G.
Venue
Journal of Biological Physics
Publisher
Springer Science and Business Media LLC
Published
2009-05-14
Volume
35
Issue
4
Pages
317-336
ISSN
  • 0092-0606
  • 1573-0689
DOI
10.1007/s10867-009-9157-9
Cited by
155
References
10
Language
en
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review